These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane. Kahn NN; Sinha AK Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882 [TBL] [Abstract][Full Text] [Related]
5. Control of erythrocyte membrane microviscosity by insulin. Dutta-Roy AK; Ray TK; Sinha AK Biochim Biophys Acta; 1985 Jun; 816(1):187-90. PubMed ID: 3890945 [TBL] [Abstract][Full Text] [Related]
6. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. Dutta-Roy AK; Sinha AK J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571 [TBL] [Abstract][Full Text] [Related]
7. Influence of cholesterol and prostaglandin E1 on the molecular organization of phospholipids in the erythrocyte membrane. A fluorescent polarization study with lipid-specific probes. Manevich EM; Lakin KM; Archakov AI; Li VS; Molotkovsky JG; Bezuglov VV; Bergelson LD Biochim Biophys Acta; 1985 May; 815(3):455-60. PubMed ID: 4039606 [TBL] [Abstract][Full Text] [Related]
8. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets. Dutta-Roy AK; Kahn NN; Sinha AK Life Sci; 1991; 49(16):1129-39. PubMed ID: 1654491 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E1 binds to Z protein of rat liver. Dutta-Roy AK; Gopalswamy N; Trulzsch DV Eur J Biochem; 1987 Feb; 162(3):615-9. PubMed ID: 3830160 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of human erythrocyte insulin binding sites. Okada Y Acta Med Okayama; 1981 Apr; 35(2):125-35. PubMed ID: 6456644 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans. Kahn NN; Bauman WA; Hatcher VB; Sinha AK Am J Physiol; 1993 Dec; 265(6 Pt 2):H2160-7. PubMed ID: 8285255 [TBL] [Abstract][Full Text] [Related]
14. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects. Jap TS; Kwok CF; Wong MC; Chiang H Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795 [TBL] [Abstract][Full Text] [Related]
15. [Effects of prostaglandin E1 on hemorheology in patients with coronary heart disease]. Ma C Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):107-8. PubMed ID: 1473476 [No Abstract] [Full Text] [Related]
17. Effect of calcium, insulin and growth hormone on membrane fluidity. A spin label study of rat adipocyte and human erythrocyte ghosts. Sauerheber RD; Lewis UJ; Esgate JA; Gordon LM Biochim Biophys Acta; 1980 Apr; 597(2):292-304. PubMed ID: 6245691 [TBL] [Abstract][Full Text] [Related]
18. Human platelet adenylate cyclase: persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities. Olson CV; Smiley PA; Lad PM Biochim Biophys Acta; 1985 Jun; 845(3):411-20. PubMed ID: 3924118 [TBL] [Abstract][Full Text] [Related]
19. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275 [TBL] [Abstract][Full Text] [Related]
20. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes. Hung SC; Ghali NI; Venton DL; Le Breton GC Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]